Skip to content

Westlake Chemical Partners stock

WLKPNYSE

Westlake Chemical Partners LP, Basic MaterialsISIN US9604171036

$21.42▲ $0.05 (+0.2%)Closing price of 11 Nov 2026

68Score 68 out of 100, Neutral

Turn on early warning

Price and trend

63 / 100

Price history

+18% in one year

The chart shows daily closes over 12 years, adjusted for stock splits and without dividends. Click into the chart to set a price alert at that price.

Long-term trend

Below the 200-day line: the price is 2.7% below it.

Trend change

Since September 2026 the 50-day line has been below the 200-day line; the trend has turned down.

Momentum

Normal: the price is neither overheated nor sold off (RSI 61).

Distance to the high

The price is 9.7% below its 52-week high. Largest decline in 12 years: 69% (September 2014 to March 2020).

Chart figures for advanced users
SMA 50$21.34
Average price of the last 50 trading days, shows the short-term trend.
SMA 200$22.00
Average price of the last 200 trading days, shows the long-term trend.
RSI (14)61
Relative strength over the last 14 days on a scale from 0 to 100. Above 70 the price counts as overheated, below 30 as sharply fallen.
MACDabove the signal line
Compares a fast and a slow price average. Above its signal line momentum is rising, below it momentum is fading.
Support$17.87
The lowest closing price of the last twelve months.
Resistance$23.72
The highest closing price of the last twelve months.
Market cap
$755.13M
Div. yield
8.8%
12 months
12.8
Fair value
$66.16

Snapshot

Computed from the data by fixed rules, no AI

  • Westlake Chemical Partners LP belongs to the Chemicals industry (United States) and, with a market value of $755.13M, is number 38 of 44 companies in its industry on MEQIRI.
  • In fiscal 2025 it reported revenue of $1.17B (up 2.7% year on year) and earnings of $48.7M (down 21.9%).
  • MEQIRI Score 68 out of 100 (Neutral): rank 107 of 467 in Basic Materials, median 58.
Show more
  • The P/E is 12.8 (Chemicals median 15.6, own median of recent years 13.9).
  • Our model puts fair value at $66.16, with the price 68% below it.

In plain words

The numbers on this page in plain words, written by an AI

Strengths

  • Earnings turn into cashFree cash flow above 500% of earnings over the last 12 months.Fundamentals 97
  • High dividend yieldDividend yield 8.8%, Chemicals median 4.14%.Capital allocation 52
  • Below fair valuePrice 68% below the fair value of $66.16.Valuation 87

Weaknesses

None of our weakness checks flags anything. Crash risk is measured separately.

68/ 100
MEQIRI Score
Neutral

Its standout strengths are fundamentals and stability, while growth holds the score back.

Daily figure as of 12 Nov 2026

How the score is calculated

Score overview

Fundamentals are strong, with stable profits and strong cash generation.

Profit consistency100% of years
Cash conversion (free cash flow to earnings, 12 months)above 500%
ROIC (12 months)31.3%
Positive free cash flow90% of years
How this category is measured

Score history

The full history of up to 20 years comes with MEQIRI Pro.

See plans

Crash risk low

How well MEQIRI warns

One of the 30% with the lowest crash risk among smaller stocks.

From 2016 to 2025, 14 in 100 such stocks fell 30% or more within a year, against a group average of 23 in 100.

What drives the risk

  • cyclical sector (energy or materials), as a group, crashed more often in the backtest

What lowers it

  • solid fundamentals
  • calm price action

Valuation

Valuation signal

Significantly undervalued
Price
$21.42
Fair value
$66.16
Gap to fair value
−68%

In our model the price counts as cheap below $47.26 and expensive above $110.27 (uncertainty high, one part of the fair value is more than twice the other).

The two parts of the fair value come to $106.12 (cash-flow model) and $26.20 (industry comparison), and the gap between them shows how uncertain the estimate is. The price is below both.

Calculated with a cost of equity of 8.8%. At 9.8% the fair value would be $57.47, at 7.8% it would be $79.18.

Valuation metrics

1.84
2.2
Fair value (model)
$66.16
Earnings part $26.20 (earnings per share $1.68 × 15.6)

Half from the cash-flow model, half from earnings times the industry P/E (15.6).

Calculate with your own assumptions

Company performance

This shows several years of history with an automatic assessment.

Revenue

15 years

In the twelve months to 30 Sep 2026, revenue rose 9.4% on the twelve months before. Revenue has declined since 2011 (-5% per year), so it is worth watching closely.

Margins

15 years
  • Gross margin
  • Operating margin
  • Net margin

In fiscal 2025: gross 30%, operating 27%, net 4%.

Debt & balance sheet

latest quarter
0.52
14.1x
3.52
Cash & equivalents
$47.65M

The balance sheet is solid, with moderate debt and comfortable interest coverage.

Earnings

Next earnings
23 Feb 2027in 103 days
Last reported
4 Nov 2026EPS reported $0.46 (expected $0.30)above expectations

Analyst estimates

Earnings estimates have barely changed since 15 Oct 2026.

Fiscal 20261 analyst
Earnings per share
$1.500.0%
Revenue
$1.36B0.0%
Fiscal 20271 analyst
Earnings per share
$1.700.0%
Revenue
$1.43B0.0%

MEQIRI has stored the estimates since 15 Oct 2026. Until 30 days are available, the card shows the change since that day. Mean estimate according to Financial Modeling Prep. No price target and no recommendation.

Insiders

Open-market purchases and sales by executives, board members and major holders

All insider purchases

No open-market purchases or sales in the last 6 months.

Source: Form 4 filings with the US Securities and Exchange Commission. Grants, option exercises, gifts and tax withholdings are hidden. Not a recommendation to buy.

What happened at Westlake Chemical Partners

The key events of the last six months from our own data. A click takes you to the matching card.

Sector comparison

467 rated companies in Basic Materials

Rank 107 of 467
107/ 467
This company
68
Sector median
58

Categories against the sector median

ProfitabilityMedian of 467 companies66 (median 49)17 above the median
GrowthMedian of 467 companies39 (median 54)15 below the median
FundamentalsMedian of 467 companies97 (median 65)32 above the median
ValuationMedian of 426 companies with a value87 (median 69)18 above the median
StabilityMedian of 467 companies91 (median 67)24 above the median
Capital allocationMedian of 467 companies52 (median 52)0 at the median
Technical analysisMedian of 467 companies63 (median 54)9 above the median
MomentumMedian of 467 companies58 (median 51)7 above the median

The median is the middle value: half of the companies in the sector lie above it, half below. Categories with too few comparable companies are left out.

Competitors in Chemicals

The next larger and next smaller companies by market value

All 44 Chemicals stocks

Data status and sources

Score
Daily value of 12 Nov 2026, recalculated nightly
Price
Closing price of 11 Nov 2026
Latest annual report
Fiscal year 2025, period end 31 Dec 2025
Source
Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.

Mandatory disclosures for this rating

  • ; time horizon around 12 months
  • Rated Neutral since 7 Nov 2026, previously Strong
  • Valuation signal Undervalued since 7 Nov 2026
  • End-of-day prices, metrics cached for up to 24 hours
  • Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
  • Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
  • Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.

MEQIRI counts visits without cookies. With your consent we remember for 90 days where you came from, also in your account, count page changes and time on page, recognise your next visit and load the Meta Pixel, which measures our advertising. You can withdraw your consent at any time under Cookie settings. Privacy